Levetiracetam Modified ReleaseTablet 750 mg

đź’Š Levetiracetam Modified Release (MR) Tablet 750 mg


📌 1. Prescription / Indication:

Levetiracetam MR 750 mg is prescribed for the treatment of epilepsy, specifically:

  • Partial-onset seizures in adults and adolescents ≥16 years
  • Used when once-daily dosing is preferred
  • Monotherapy or adjunctive therapy

đź“„ 2. Description:

  • Form: Modified Release (MR) / Extended Release (XR) tablet
  • Strength: 750 mg
  • Appearance: Varies by manufacturer—often oblong, film-coated
  • Route: Oral
  • Pharmacokinetics:
    • Designed for slow and steady drug release over 24 hours
    • Maintains stable plasma levels
    • Once-daily dosing improves adherence

🔬 3. Nature / Class:

  • Therapeutic class: Antiepileptic (AED)
  • Mechanism of Action:
    Binds to SV2A (synaptic vesicle protein 2A) in the brain to reduce abnormal neuronal firing and prevent seizures.

🌟 4. Advantages:

  • Once-daily dosing improves convenience and compliance
  • Reduced fluctuations in plasma levels
  • Fewer side effects like sedation compared to immediate-release (IR)
  • Useful for long-term maintenance therapy
  • Can be used in combination with other AEDs

📦 5. Common Packaging:

FormDetails
Blister packs10 tablets per strip
BoxesUsually 3–10 strips per box
HDPE bottlesAvailable in some settings

đź§Š 6. Storage:

  • Store at 15°C to 30°C (59–86°F)
  • Keep away from heat and moisture
  • Protect from light
  • Store in original packaging until use
  • Keep out of reach of children

👩‍⚕️ 7. Patient Advice:

  • Swallow whole—do not crush, chew, or break MR tablets
  • Take at the same time daily (preferably evening)
  • Do not skip or stop abruptly—can trigger seizures
  • May cause drowsiness, dizziness, or mood changes
  • Report unusual behavior, suicidal thoughts, or skin reactions
  • Not usually recommended during pregnancy unless necessary
  • Renal function should be monitored; dose adjustments may be required

🎯 8. Purpose / Uses:

Seizure TypeUse
Partial-onset seizuresLong-term management
Generalized epilepsy*Off-label in some cases

* Based on physician’s discretion and clinical context


⚠️ 9. Precautions / Warnings:

  • Renal impairment: Dose modification required
  • Hepatic impairment: Generally safe, minimal liver metabolism
  • Avoid alcohol or sedatives during therapy
  • Monitor mood/behavioral changes in patients
  • Not interchangeable with immediate-release without dose adjustment

Leave a Comment

Your email address will not be published. Required fields are marked *

Call Now Button